Possibilities and Predictions...., page-8

Yes lowed,hopefully an update from GSK is just around the corner ,as the company mentioned in the June newsletter,possibly an update before Christmas ,we know ph1 trial was completed back in March ,and that GSK ,discontinued certain trials and that they stated they were preparing for another trial with 731.We also know the trial was quiet extensive stretching over 3 years and testing for safety and tolerability in 63 patients ,but most importantly it was also testing for clinical endpoints and was a randomised double blind ,placebo controlled trial testing also for mechanisms of action.